The latest quarterly R&D expense is $29.95 Million with a QoQ Growth of -11.37%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $29.95M.
$29.95M
$29.95 Million
Q2 FY2026 · 2026-06-30
-11.37%
vs. $33.78M prior quarter
56
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $29.95M | -11.37% | -8.67% |
| Q1 FY2026Period end 2026-03-31 | $33.78M | +22.11% | -2.41% |
| Q4 FY2025Period end 2025-12-31 | $27.67M | -9.42% | -16.92% |
| Q3 FY2025Period end 2025-09-30 | $30.54M | -6.84% | -15.47% |
| Q2 FY2025Period end 2025-06-30 | $32.79M | -5.29% | -14.35% |
| Q1 FY2025Period end 2025-03-31 | $34.62M | +3.95% | -2.04% |
| Q4 FY2024Period end 2024-12-31 | $33.30M | -7.84% | -15.27% |
| Q3 FY2024Period end 2024-09-30 | $36.13M | -5.61% | +1.63% |
| Q2 FY2024Period end 2024-06-30 | $38.28M | +8.32% | +21.61% |
| Q1 FY2024Period end 2024-03-31 | $35.34M | -10.09% | +9.28% |
| Q4 FY2023Period end 2023-12-31 | $39.30M | +10.55% | +27.07% |
| Q3 FY2023Period end 2023-09-30 | $35.55M | +12.95% | +13.37% |
| Q2 FY2023Period end 2023-06-30 | $31.48M | -2.67% | -28.96% |
| Q1 FY2023Period end 2023-03-31 | $32.34M | +4.55% | -23.12% |
| Q4 FY2022Period end 2022-12-31 | $30.93M | -1.36% | -29.70% |
| Q3 FY2022Period end 2022-09-30 | $31.36M | -29.23% | -31.54% |
| Q2 FY2022Period end 2022-06-30 | $44.31M | +5.34% | +30.39% |
| Q1 FY2022Period end 2022-03-31 | $42.06M | -4.41% | +13.53% |
| Q4 FY2021Period end 2021-12-31 | $44.00M | -3.94% | +18.34% |
| Q3 FY2021Period end 2021-09-30 | $45.81M | +34.80% | +23.68% |
| Q2 FY2021Period end 2021-06-30 | $33.98M | -8.28% | -20.22% |
| Q1 FY2021Period end 2021-03-31 | $37.05M | -0.36% | +8.98% |
| Q4 FY2020Period end 2020-12-31 | $37.19M | +0.40% | +17.75% |
| Q3 FY2020Period end 2020-09-30 | $37.04M | -13.05% | +40.99% |
| Q2 FY2020Period end 2020-06-30 | $42.59M | +25.29% | +60.63% |
| Q1 FY2020Period end 2020-03-31 | $34.00M | +7.66% | -10.47% |
| Q4 FY2019Period end 2019-12-31 | $31.58M | +20.21% | -18.80% |
| Q3 FY2019Period end 2019-09-30 | $26.27M | -0.93% | -27.88% |
| Q2 FY2019Period end 2019-06-30 | $26.52M | -30.17% | -40.72% |
| Q1 FY2019Period end 2019-03-31 | $37.97M | -2.36% | -8.10% |
| Q4 FY2018Period end 2018-12-31 | $38.89M | +6.76% | +11.65% |
| Q3 FY2018Period end 2018-09-30 | $36.43M | -18.57% | +44.34% |
| Q2 FY2018Period end 2018-06-30 | $44.73M | +8.26% | +93.49% |
| Q1 FY2018Period end 2018-03-31 | $41.32M | +18.63% | +71.58% |
| Q4 FY2017Period end 2017-12-31 | $34.83M | +38.02% | +68.51% |
| Q3 FY2017Period end 2017-09-30 | $25.24M | +9.16% | +26.86% |
| Q2 FY2017Period end 2017-06-30 | $23.12M | -4.00% | -5.94% |
| Q1 FY2017Period end 2017-03-31 | $24.08M | +16.51% | +10.50% |
| Q4 FY2016Period end 2016-12-31 | $20.67M | +3.91% | -14.10% |
| Q3 FY2016Period end 2016-09-30 | $19.89M | -19.07% | -23.26% |
| Q2 FY2016Period end 2016-06-30 | $24.58M | +12.77% | -8.99% |
| Q1 FY2016Period end 2016-03-31 | $21.80M | -9.43% | +5.03% |
| Q4 FY2015Period end 2015-12-31 | $24.06M | -7.17% | +20.09% |
| Q3 FY2015Period end 2015-09-30 | $25.92M | -4.01% | +62.52% |
| Q2 FY2015Period end 2015-06-30 | $27.01M | +30.14% | +105.23% |
| Q1 FY2015Period end 2015-03-31 | $20.75M | +3.56% | +89.01% |
| Q4 FY2014Period end 2014-12-31 | $20.04M | +25.62% | +106.81% |
| Q3 FY2014Period end 2014-09-30 | $15.95M | +21.22% | +106.14% |
| Q2 FY2014Period end 2014-06-30 | $13.16M | +19.86% | +117.15% |
| Q1 FY2014Period end 2014-03-31 | $10.98M | +13.31% | +121.13% |
| Q4 FY2013Period end 2013-12-31 | $9.69M | +25.21% | +164.29% |
| Q3 FY2013Period end 2013-09-30 | $7.74M | +27.69% | N/A |
| Q2 FY2013Period end 2013-06-30 | $6.06M | +22.05% | N/A |
| Q1 FY2013Period end 2013-03-31 | $4.96M | +35.43% | N/A |
| Q4 FY2012Period end 2012-12-31 | $3.67M | N/A | N/A |
| Q3 FY2012Period end 2012-09-30 | $3.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
